Kamyar Afarinkia

Kamyar Afarinkia

University of Bradford

H-index: 23

Europe-United Kingdom

About Kamyar Afarinkia

Kamyar Afarinkia, With an exceptional h-index of 23 and a recent h-index of 11 (since 2020), a distinguished researcher at University of Bradford,

His recent articles reflect a diverse array of research interests and contributions to the field:

Synthesis and folding properties of?-hydroxy phenylphosphinate pseudopeptides

Niosomal delivery of Celecoxib and Metformin for targeted breast cancer treatment

Discovery of 2, 4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms

tert-Butyl(2-oxo-2H-pyran-5-yl)carbamate as the First Chameleon Diene Bearing an Electron-Donating Substituent

The Use of MM/QM Calculations of 13C Chemical Shifts in the Analysis of Edaravone Tautomers

The expression of Glutaminases and their association with Clinicopathological parameters in the head and neck cancers

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens

Synthesis and evaluation of FPR1 inhibitors as a novel treatment for cancers

Kamyar Afarinkia Information

University

Position

Institute of Cancer Therapeutics Richmond Road Bradford BD7 1DP UK

Citations(all)

2157

Citations(since 2020)

469

Cited By

1797

hIndex(all)

23

hIndex(since 2020)

11

i10Index(all)

49

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Top articles of Kamyar Afarinkia

Synthesis and folding properties of?-hydroxy phenylphosphinate pseudopeptides

2023/10/18

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

Niosomal delivery of Celecoxib and Metformin for targeted breast cancer treatment

Cancers

2023/10/16

Ahlam Zaid Alkilani
Ahlam Zaid Alkilani

H-Index: 10

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

Discovery of 2, 4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms

Journal of Enzyme Inhibition and Medicinal Chemistry

2022/12/31

Alessio Nocentini
Alessio Nocentini

H-Index: 28

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

tert-Butyl(2-oxo-2H-pyran-5-yl)carbamate as the First Chameleon Diene Bearing an Electron-Donating Substituent

Molecules

2022/9/2

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

The Use of MM/QM Calculations of 13C Chemical Shifts in the Analysis of Edaravone Tautomers

Journal of Solution Chemistry

2022/9

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

The expression of Glutaminases and their association with Clinicopathological parameters in the head and neck cancers

Current Cancer Drug Targets

2022/2/1

Keith Hunter
Keith Hunter

H-Index: 31

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens

RSC Advances

2022/11/2

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

Mohammed As Abourehab
Mohammed As Abourehab

H-Index: 12

Synthesis and evaluation of FPR1 inhibitors as a novel treatment for cancers

Cancer Research

2021/7/1

Descriptors for Edaravone; studies on its structure, and prediction of properties

Journal of Molecular Liquids

2021/6/15

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

CCR7 as a therapeutic target in Cancer

2021/1/1

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

Application of small molecule FPR1 antagonists in the treatment of cancers

Scientific reports

2020/10/14

The assessment of intramolecular hydrogen bonding in ortho-substituted anilines by an NMR method

Journal of Molecular Liquids

2020/10/1

Kamyar Afarinkia
Kamyar Afarinkia

H-Index: 10

Structure-activity relationships of FPR1 antagonist for the treatment of glioma

American Chemical Society SciMeetings

2020/3/22

See List of Professors in Kamyar Afarinkia University(University of Bradford)